Belgium· BE-AMP-SAM112217-00
Bromhydrate de Scopolamine 0,50 mg/ml
A medicinal product containing hyoscine hydrobromide, registered in Belgium by Laboratoires Sterop.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Hyoscine Hydrobromide
- Manufacturer
- Laboratoires Sterop
- Country
- Belgium (BE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb1847995
- be_apb1847979
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hyoscine hydrobromide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainESCOPOLAMINA B. BRAUN 0,5 mg/ml SOLUCIÓN INYECTABLEB Braun Medical S.A.
- United KingdomHyoscine 1mg/72hours transdermal patchesImported
- United StatesscopolamineActavis Pharma, Inc.
- FranceBROMHYDRATE DE SCOPOLAMINE RENAUDIN 0,025 %, solution injectableLABORATOIRE RENAUDIN
- FinlandOftan-ScopolaminSanten Oy
- CanadaSCOPOLAMINE HYDROBROMIDE INJECTIONOMEGA LABORATORIES LIMITED
- IrelandHyoscine Hydrobromide Martindale Pharma 600 micrograms/ml Solution for InjectionEthypharm
- GermanyBoro-Scopol NOmnivision Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Germany · Boro-Scopol N, Scopoderm Tts
- Denmark · Scopoderm
- Spain · Escopolamina B. Braun
- Finland · Scopoderm
- France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
- United Kingdom (Northern Ireland) · Hyoscine Hydrobromide Wockhardt Uk, Hyoscine Martindale Pharma
- Ireland · Hyoscine Injection Bp Ethypharm, Kwells
- Iceland · Scopoderm
- Luxembourg · Scopoderm Tts
- Malta · Kwells
- Netherlands · Scopoderm
- Norway · Scopoderm
- Sweden · Scopoderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bbf5f47c-9d84-48ee-a78f-939fce03c726 GET /v1/drugs/bbf5f47c-9d84-48ee-a78f-939fce03c726?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solvent for parenteral use",
"source": "afmps",
"status": "REVOKED",
"name_en": "Bromhydrate de Scopolamine 0,50 mg/ml",
"name_fr": "Bromhydrate de Scopolamine 0,50 mg/ml",
"name_nl": "Bromhydrate de Scopolamine 0,50 mg/ml",
"amp_code": "SAM112217-00",
"strengths": [
"0.5000"
],
"pack_count": 2,
"substances": [
"Hyoscine Hydrobromide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": null,
"authorisation_numbers": [
"0301P 0034F012"
]
}See everything about hyoscine hydrobromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.